HIGHLIGHTS
- who: Long-Acting Luteinizing Hormone-Releasing and collaborators from the Department of Obstetrics and Gynecology, Rokko Island Konan Hospital, Kobe, Japan have published the research: Case Report Long-Acting Luteinizing Hormone-Releasing Hormone Agonist for Ovarian Hyperstimulation Induced by Tamoxifen for Breast Cancer, in the Journal: Case Reports in Obstetrics and Gynecology of 23/01/2018
- what: The authors report successful management with (LHRH) agonist of ovarian hyperstimulation induced by tamoxifen.
SUMMARY
Tamoxifen is a selective estrogen receptor modulator (SERM), which is widely used as hormone therapy for estrogenreceptor-positive breast . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.